Free Trial

EUDA Health (EUDA) Competitors

EUDA Health logo
$2.60 +0.17 (+7.00%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$2.56 -0.04 (-1.73%)
As of 08/22/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EUDA vs. TOI, LFMD, VMD, XGN, CORBF, DCGO, BNR, QIPT, NAKA, and SERA

Should you be buying EUDA Health stock or one of its competitors? The main competitors of EUDA Health include Oncology Institute (TOI), LifeMD (LFMD), Viemed Healthcare (VMD), Exagen (XGN), Global Cord Blood (CORBF), DocGo (DCGO), Burning Rock Biotech (BNR), Quipt Home Medical (QIPT), KindlyMD (NAKA), and Sera Prognostics (SERA). These companies are all part of the "healthcare" industry.

EUDA Health vs. Its Competitors

Oncology Institute (NASDAQ:TOI) and EUDA Health (NASDAQ:EUDA) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

36.9% of Oncology Institute shares are owned by institutional investors. Comparatively, 4.4% of EUDA Health shares are owned by institutional investors. 8.5% of Oncology Institute shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Oncology Institute had 3 more articles in the media than EUDA Health. MarketBeat recorded 3 mentions for Oncology Institute and 0 mentions for EUDA Health. Oncology Institute's average media sentiment score of 0.88 beat EUDA Health's score of 0.00 indicating that Oncology Institute is being referred to more favorably in the media.

Company Overall Sentiment
Oncology Institute Positive
EUDA Health Neutral

Oncology Institute currently has a consensus target price of $7.00, indicating a potential upside of 84.70%. Given Oncology Institute's higher probable upside, research analysts plainly believe Oncology Institute is more favorable than EUDA Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oncology Institute
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
EUDA Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

Oncology Institute has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500. Comparatively, EUDA Health has a beta of -0.06, suggesting that its stock price is 106% less volatile than the S&P 500.

EUDA Health has a net margin of 0.00% compared to Oncology Institute's net margin of -14.26%. EUDA Health's return on equity of 0.00% beat Oncology Institute's return on equity.

Company Net Margins Return on Equity Return on Assets
Oncology Institute-14.26% -1,527.21% -34.25%
EUDA Health N/A N/A N/A

EUDA Health has lower revenue, but higher earnings than Oncology Institute.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oncology Institute$393.41M0.86-$64.66M-$0.68-5.57
EUDA Health$4.01M24.09-$15.36MN/AN/A

Summary

Oncology Institute beats EUDA Health on 8 of the 14 factors compared between the two stocks.

Get EUDA Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for EUDA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EUDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EUDA vs. The Competition

MetricEUDA HealthMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$90.36M$2.08B$5.76B$9.58B
Dividend YieldN/AN/A4.41%4.10%
P/E RatioN/A38.6631.1026.05
Price / Sales24.0910.17432.51103.82
Price / CashN/A51.9937.7358.48
Price / Book-37.146.709.536.61
Net Income-$15.36M-$63.67M$3.26B$265.56M
7 Day Performance2.36%4.61%2.10%1.97%
1 Month Performance-15.86%0.23%2.81%-0.36%
1 Year Performance-42.92%26.48%30.56%19.03%

EUDA Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EUDA
EUDA Health
N/A$2.60
+7.0%
N/A-43.8%$90.36M$4.01M0.002Gap Up
TOI
Oncology Institute
2.8805 of 5 stars
$3.82
-5.4%
$7.00
+83.2%
+996.0%$360.51M$393.41M-5.62660Short Interest ↓
LFMD
LifeMD
2.6501 of 5 stars
$6.11
-6.1%
$12.86
+110.4%
+25.1%$308.92M$212.45M-29.10230
VMD
Viemed Healthcare
2.0993 of 5 stars
$6.95
+0.4%
N/A+1.2%$268.40M$224.26M20.441,179Positive News
XGN
Exagen
3.7482 of 5 stars
$9.65
-1.0%
$11.25
+16.6%
+231.1%$214.54M$55.64M-10.84220Short Interest ↑
CORBF
Global Cord Blood
N/A$1.40
+12.0%
N/A+53.5%$170.17M$196.12M0.001,200
DCGO
DocGo
2.1504 of 5 stars
$1.59
-5.4%
$3.56
+123.9%
-50.3%$164.32M$616.55M-8.374,407Analyst Forecast
BNR
Burning Rock Biotech
0.3651 of 5 stars
$9.39
-7.7%
N/A+45.3%$109.44M$70.67M-4.971,390Upcoming Earnings
Gap Down
QIPT
Quipt Home Medical
3.3543 of 5 stars
$2.17
-4.0%
$3.15
+45.2%
-21.8%$98.18M$245.91M-9.041,200Analyst Forecast
NAKA
KindlyMD
N/A$10.62
-11.6%
N/AN/A$90.72M$2.72M-12.35N/ANews Coverage
SERA
Sera Prognostics
1.0785 of 5 stars
$2.25
-5.5%
N/A-66.3%$89.66M$80K-2.65120News Coverage

Related Companies and Tools


This page (NASDAQ:EUDA) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners